Medicare Enrolled
Dr. Maged Azer, M.D.
Cardiovascular Disease · Orange, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Azer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Azer
Dr. Maged Azer is a cardiovascular disease specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Azer performed 4,805 Medicare services across 2,818 unique beneficiaries.
Between the years covered by Open Payments, Dr. Azer received a total of $9,561 from 40 pharmaceutical and/or device companies across 498 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Azer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in CA
$9,561 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,805
Medicare services
Top 21% in CA for cardiovascular disease
2,818
Unique beneficiaries
$194
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~253 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,209 | $43 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
777 | $103 | $278 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 440 | $417 | $1,050 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
425 | $12 | $32 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
302 | $62 | $157 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
246 | $173 | $451 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
220 | $1,741 | $4,400 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
166 | $76 | $222 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
154 | $125 | $310 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
85 | $66 | $179 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
83 | $407 | $1,037 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
79 | $47 | $124 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
79 | $22 | $55 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
79 | $198 | $533 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
78 | $153 | $388 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
74 | $102 | $244 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
48 | $25 | $63 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $139 | $359 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
38 | $22 | $54 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
38 | $798 | $2,003 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $149 | $378 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
26 | $180 | $440 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
21 | $55 | $152 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
18 | $87 | $225 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
15 | $10 | $25 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
12 | $190 | $471 |
| New patient office visit, complex (60-74 min) | 12 | $193 | $475 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.2% high complexity
45.4% medium
44.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,561
Total received (2018-2024)
Avg $1,366/year across 7 years
Top 28% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
498
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,921 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$641 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,170
2023
$888
2022
$969
2021
$1,129
2020
$2,089
2019
$1,633
2018
$1,684
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$305
Novartis Pharmaceuticals Corporation
$167
CVRx, Inc.
$152
ABIOMED
$64
Amgen Inc.
$59
E.R. Squibb & Sons, L.L.C.
$58
Edwards Lifesciences Corporation
$55
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
SCPHARMACEUTICALS INC.
$36
Janssen Pharmaceuticals, Inc
$31
Kiniksa Pharmaceuticals International, plc
$29
Actelion Pharmaceuticals US, Inc.
$23
Regeneron Healthcare Solutions, Inc.
$21
PFIZER INC.
$20
Novo Nordisk Inc
$18
Medtronic, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$17
Top 3 companies account for 53.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,859
Novartis Pharmaceuticals Corporation
$1,618
SANOFI-AVENTIS U.S. LLC
$751
PFIZER INC.
$656
Amgen Inc.
$653
Boehringer Ingelheim Pharmaceuticals, Inc.
$648
Astellas Pharma US Inc
$558
Janssen Pharmaceuticals, Inc
$366
ShockWave Medical, Inc
$305
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$297
CVRx, Inc.
$212
Boston Scientific Corporation
$167
Gilead Sciences, Inc.
$166
Kowa Pharmaceuticals America, Inc.
$163
E.R. Squibb & Sons, L.L.C.
$160
GENZYME CORPORATION
$125
Edwards Lifesciences Corporation
$106
ABIOMED
$87
AstraZeneca Pharmaceuticals LP
$70
HeartFlow, Inc.
$57
Bardy Diagnostics, Inc.
$54
SCPHARMACEUTICALS INC.
$51
PORTOLA PHARMACEUTICALS, INC.
$40
iRhythm Technologies, Inc.
$40
Kestra Medical Technology Services, Inc.
$38
Lundbeck LLC
$32
Allergan Inc.
$32
Kiniksa Pharmaceuticals International, plc
$29
Cardiovascular Systems Inc.
$27
Amarin Pharma Inc.
$24
Actelion Pharmaceuticals US, Inc.
$23
Regeneron Healthcare Solutions, Inc.
$21
Daiichi Sankyo Inc.
$21
Novo Nordisk Inc
$18
Medtronic, Inc.
$17
Ultragenyx Pharmaceutical Inc.
$17
Medtronic Vascular, Inc.
$17
ATRICURE, INC.
$13
Merck Sharp & Dohme LLC
$12
Esperion Therapeutics, Inc.
$11
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · Absolute Pro vascular stent system · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · COREVALVE EVOLUT R · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · Diamondback Coronary · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · EVOQUE · FARXIGA · FUROSCIX · GENERAL THERAPIES · GENERAL THERAPIES · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · INJECTAFER · Impella · JARDIANCE · LEQVIO · LEXISCAN · LUX-DX · Lexiscan · LifeVest · Livalo · MULTAQ · Mitra Clip system · MitraClip System · NEXLIZET · NORTHERA · OPSUMIT · OPTIS · Ozempic · PASCAL · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · RESONATE · Repatha · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Tricuspid Valve Repair System · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
332
Per 100K population
10.5
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Azer is a cardiac imaging specialist, with above-average Medicare volume (top 21% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Azer experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Azer performed 1,209 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azer receive payments from pharmaceutical companies?
Yes. Dr. Azer received a total of $9,561 from 40 companies across 498 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azer's costs compare to other cardiologists in Orange?
Dr. Azer's average Medicare payment per service is $194. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Orange
Browse cardiologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology